Author:
Suga Shigeru,Ishiwada Naruhiko,Sasaki Yuko,Akeda Hideki,Nishi Junichiro,Okada Kenji,Fujieda Mikiya,Oda Megumi,Asada Kazutoyo,Nakano Takashi,Saitoh Akihiko,Hosoya Mitsuaki,Togashi Takehiro,Matsuoka Mayumi,Kimura Kouji,Shibayama Keigo
Funder
Ministry of Health, Labor and Welfare of Japan
Japan Agency for Medical Research and development (AMED)
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference38 articles.
1. Haemophilus influenzae type b conjugate vaccine use and effectiveness;Morris;Lance Infect Dis,2008
2. Haemophilus influenzae type b (Hib) vaccine position paper;World Health Organization;Wkly Epidemiol Rec,2013
3. World Health Organization. WHO vaccine-preventable disease monitoring system 2018 global summary. Estimated coverage in country. .
4. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates;Peltola;Clin Microbiol Rev,2000
5. Centers for Disease Control and Prevention (CDC). Progress toward elimination of Haemophilus influenzae type b disease among infants and children–United States, 1987–1995. MMWR Morb Mortal Wkly Rep 1996;45:901–6.
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献